
Q3 earnings · Hims & Hers Health
Hims & Hers cuts its adjusted EBITDA outlook even as revenue jumps 49% to $890M
The telehealth company lowered its 2026 adjusted EBITDA forecast to $257 million to $277 million, swung to a $33 million net loss and disclosed paid agreements tied to new director Andrew Huberman.


